TNS Watchlist for 2/16/2010
CRXX - CombinatoRx Incorporated - Again, this was a previous TNS pick, we brought investor awareness to CRXX and instantly this Nadsaq stock soared from $1.76 to $2.60 from our world famous due diligence alert back in Sept. 2009. Whether NYSE, NASDAQ, AMEX, PINK, or OTCBB, no exchange is safe from TooNiceStocks world famous due diligence alert and reach. CRXX was added on 1/20/2010 to our world famous Biotech watchlist and trading at $.92. Guess what? CRXX closed on last Friday at $1.29, yielding a potential 40% return on investment! TOONICE continues his "BUY" rating because he sees more upside heading toward the big catalyst, which is FDA decision date 2/22/2010 on their topline product Exalgo. Here at TooNiceStocks, we have REAL WORLD research analyst covering all sectors. We talk INTELLIGENTLY to our members by providing great due diligence.
CVM - Cel-Sci Corporation - Back in September TNS members were alerted to a AMEX exchange traded CVM. We rode CVM from $.78 to $2.00, as our world famous due diligence alert was able to add to the BUZZzzz coming from other sources like www.BioMedReports.com. Similiar to a recent pick BMOD, which helped our members make up to 83.33% recently. At these levels CVM is a steal after long time www.theStreet.com analyst Adam Feuerstein continues his PR onslaught of CVM. Adam states in his recent article, which can be found here, "Cel-Sci has no data on the real survival benefit of Multikine from a randomized, controlled study, so it arbitrarily compares the drug to studies found in the scientific literature between 1987 and 2004. Why these studies? Why these years? Why not 1986 or 2005? Cel-Sci doesn't say." His article was able to make the shorters happy by sending CVM down to an intraday low of $.53. At the sametime, savvy retail investors knew it wouldn't be long before CVM comes back with a counter PR, that is what TOONICE expects and that is why CVM jumped right back up with a end of day rally this past Friday, finishing up 17.17% at $.63.